课题基金 / 基金详情

EUKARYOTIC TRANSCRIPTION COMPLEXES

EUKARYOTIC TRANSCRIPTION COMPLEXES
真核转录复合物
批准号:
2668516
负责人:
RICHARD H. EBRIGHT
金额:
$14.93万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-03-01 至 2000-02-29

项目摘要

项目成果

RICHARD H. EBRIGHT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Efficient transcription initiation at eukaryotic protein- encoding genes requires RNA polymerase II and six general transcription factors (GTFs): i.e., TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH. Human RNA polymerase II contains 10 to 12 polypeptide chains; collectively, TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH contain at least 25 distinct polypeptide chains. Understanding human transcription initiation and transcription regulation will require elucidation of the organization of these at least 35 distinct polypeptide chains relative to promoter DNA and relative to each other. TFIID, a multisubunit factor consisting of the TATA-element binding protein (TBP) and at least eight TBP-associated factors (TAFs), is the factor responsible for recognition of promoter DNA. TFIID, or isolated TBP, binds to promoter DNA and nucleates the subsequent, step-wise binding of TFIIA, TFIIB, TFIIF-RNA polymerase II, TFIIE, and TFIIH. It is believed that TBP contains determinants for protein-protein interactions with RNA polymerase II, GTFs, TAFs, and a number of transcription activators and repressors. The recent availability of the crystallographic structure of the TBP-DNA complex makes possible a detailed structure-function determination of TBP-RNA polymerase II, TBP-GTF, TBP-TAF, TBP-activator, and TBP- repressor interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bacterial Transcription Complexes
  • 批准号:
    10388566
  • 项目类别:
  • 资助金额:
    $5.1万
  • 财政年份:
    2021
  • 负责人:
    RICHARD H. EBRIGHT
  • 依托单位:
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols
Therapeutics for Drug-Resistant Bacteria: Pseudouridimycins
  • 批准号:
    8978290
  • 项目类别:
  • 资助金额:
    $102.17万
  • 财政年份:
    2013
  • 负责人:
    RICHARD H. EBRIGHT
  • 依托单位:
海外基金